Boehringer Ingelheim v. Barr Laboratories

CourtUnited States District Courts. 3th Circuit. United States District Court (Delaware)
Citation562 F.Supp.2d 619
Docket NumberCivil Action No. 05-700-JJF.
PartiesBOEHRINGER INGELHEIM INTERNATIONAL GMBH and Boehringer Ingelheim Pharmaceuticals, Inc., Plaintiffs, v. BARR LABORATORIES, INC. and Mylan Pharmaceuticals, Inc., Defendants.
Decision Date26 June 2008
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
5 cases
  • Boehringer Ingelheim Intern. v. Barr Laboratories
    • United States
    • United States Courts of Appeals. United States Court of Appeals for the Federal Circuit
    • 25 Enero 2010
    ...for treating Parkinson's disease), resulting in the '374 patent (the grandparent). Boehringer Ingelheim Int'l GMBH v. Barr Labs., Inc., 562 F.Supp.2d 619, 625 The '197 application (the parent), a divisional of the '947 application, was not consonant with the original restriction requirement......
  • Fed. Trade Comm'n v. Boehringer Ingelheim Pharm., Inc., Case No. 09-mc-564 (GMH)
    • United States
    • United States District Courts. United States District Court (Columbia)
    • 27 Septiembre 2016
    ...sued Barr for patent infringement in what is termed the “Mirapex litigation.” See Boehringer Ingelheim Int'l GmbH v. Barr Labs., 562 F.Supp.2d 619, 622 (D.Del.2008), rev'd 592 F.3d 1340 (Fed.Cir.2010). After Boehringer lost at trial but won a reversal from the Federal Circuit on appeal, the......
  • Fed. Trade Comm'n v. Boehringer Ingelheim Pharm., Inc., Case No. 09–mc–564 (GMH)
    • United States
    • United States District Courts. United States District Court (Columbia)
    • 15 Marzo 2017
    ...Aggrenox and Mirapex, and Boehringer sued Barr for patent infringement. See Boehringer Ingelheim Int'l GmbH v. Barr Labs. , 562 F.Supp.2d 619, 622 (D. Del. 2008), rev'd 592 F.3d 1340 (Fed. Cir. 2010). After Boehringer lost at trial but won on appeal before the Federal Circuit, the parties a......
  • Fed. Trade Comm'n v. Boehringer Ingelheim Pharms., Inc., Misc. Action No. 09- 564 (JMF)
    • United States
    • United States District Courts. United States District Court (Columbia)
    • 27 Septiembre 2012
    ...the generic versions, leading to litigation by BIPI alleging patent infringement. See Boehringer Ingelheim Inter. gmbH v. Barr Labs., 562 F. Supp. 2d 619, 622 (D. Del. 2008), rev'd Boehringer Ingelheim Intgern, gmbH v. Barr Labs., Inc., 592 F.3d 1340 (Fed. Cir. 2010). This action was consol......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT